Literature DB >> 2895693

Lack of acetylaminofluorene--DNA adduct formation in enzyme-altered foci of rat liver.

H S Huitfeldt1, J M Hunt, H C Pitot, M C Poirier.   

Abstract

Formation of the N-(deoxyguanosin-8-yl)-aminofluorene adduct was studied in enzyme-altered foci induced by four different liver carcinogenesis models. Foci were detected and scored for enzyme phenotype by a computer-aided image overlay technique. Localization of the enzymes gamma-glutamyl transpeptidase, canalicular ATPase and glucose-6-phosphatase was performed by enzyme histochemistry, allowing identification of foci of seven different phenotypes. Patterns of foci obtained by image overlay were compared to in situ 2-acetylaminofluorene--DNA adduct distribution obtained by immunofluorescence. Foci were induced by the following models: (1) chronic feeding of 0.02% 2-acetylaminofluorene (2-AAF) for 8 weeks; (2) intubation of diethylnitrosamine (DEN) (10 mg/kg) 24 h after a 70% partial hepatectomy (PH), followed 8 weeks later by a diet containing 0.05% phenobarbital for 9 months; (3) intubation of DEN (10 mg/kg) 24 h after PH, followed by a diet containing 0.01% ciprofibrate for 5 months, and after an additional 4 months a diet containing 0.05% phenobarbital for 2 months; (4) maintenance for 7.5, 16.5 or 19.5 months after transplantation of DEN/2-AAF/PH ('Solt-Farber' protocol) donor liver cells into host rats receiving a brief 2-AAF/PH selective regimen then no further treatment until sacrifice. To test the capacity of both foci and morphologically normal livers to form DNA adducts, the animals in models 2-4 received a diet containing 0.02% 2-AAF for 5 or 6 days before sacrifice. In all of the enzyme-altered foci identified in models 1-3 there were no DNA adducts visible by immunofluorescence. Scattered groups of positive cells were occasionally seen in the otherwise dark foci induced by model 4. For technical reasons some enzyme-altered foci were not identifiable on the fluorescence-stained slides. In liver serial sections from rats in models 1-4, there were 75, 304, 125 and 68 enzyme-altered foci of seven different phenotypes which were identified as AF-DNA negative. In models 1 and 4 there were some additional adduct-negative foci not associated with any of the seven identified focus phenotypes. These studies demonstrate that loss of the ability to form DNA adducts in hepatic enzyme-altered foci is a common and very early biochemical adaptation to xenobiotic exposure in different hepatocarcinogenesis models. This adaptation also is retained by the majority of foci in later stages of hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895693     DOI: 10.1093/carcin/9.4.647

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  5 in total

1.  Reduced DNA adduct formation in replicating liver cells during continuous feeding of a chemical carcinogen.

Authors:  H S Huitfeldt; P Brandtzaeg; M C Poirier
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  CCAAT/enhancer-binding protein (C/EBP) immunoreactivity during rat liver carcinogenesis.

Authors:  E Skarpen; B Lindeman; G H Thoresen; M Låg; T Christoffersen; H S Huitfeldt
Journal:  Histochem Cell Biol       Date:  1995-10       Impact factor: 4.304

Review 3.  Role of genotoxic and nongenotoxic effects in multistage carcinogenicity of aromatic amines.

Authors:  H G Neumann; R Hammerl; W Hillesheim; M Wildschütte
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

4.  Decrease in the metabolic activating capacities of arylamines in livers bearing hyperplastic nodules: association with the selective changes in hepatic P-450 isozymes.

Authors:  S Ozawa; M Abu-Zeid; N Murayama; Y Yamazoe; R Kato
Journal:  Jpn J Cancer Res       Date:  1990-03

5.  Epidermal growth factor receptor levels are reduced in mice with targeted disruption of the protein kinase A catalytic subunit.

Authors:  Morten P Oksvold; Ane Funderud; Anne-Katrine Kvissel; Ellen Skarpen; Heidi Henanger; Henrik S Huitfeldt; Bjørn S Skålhegg; Sigurd Ørstavik
Journal:  BMC Cell Biol       Date:  2008-04-01       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.